您好, 歡迎來到化工儀器網(wǎng)! 登錄| 免費(fèi)注冊| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置:深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司>>藥物雜質(zhì)對照品>>雜質(zhì)>> 利格列汀雜質(zhì) 結(jié)構(gòu)確證
產(chǎn)品型號
品 牌其他品牌
廠商性質(zhì)生產(chǎn)商
所 在 地深圳市
更新時間:2017-12-05 16:34:49瀏覽次數(shù):473次
聯(lián)系我時,請告知來自 化工儀器網(wǎng)奧美拉唑雜質(zhì) 對照品標(biāo)準(zhǔn)品
莫西沙星雜質(zhì) 對照品標(biāo)準(zhǔn)品
伊馬替尼雜質(zhì) 對照品標(biāo)準(zhǔn)品
依折麥布雜質(zhì) 對照品標(biāo)準(zhǔn)品
利格列汀雜質(zhì) 結(jié)構(gòu)確證? 產(chǎn)品介紹:
隨貨提供:所有雜質(zhì)對照品均隨貨提供HPLC,NMR,MS圖譜及CoA證書。
雜質(zhì)定制服務(wù):我司有專業(yè)研發(fā)團(tuán)隊,可提供雜質(zhì)定制服務(wù),以zui大可能的滿足您對雜質(zhì)對照品的選購需求。
利格列汀雜質(zhì) 結(jié)構(gòu)確證? 產(chǎn)品信息請:
何 :phastandards
國產(chǎn)進(jìn)口品牌皆有銷售,部分雜質(zhì)長期備有庫存,可快速發(fā)貨。
? 雜質(zhì)列表:
中文名稱 | 英文名稱 |
利格列汀標(biāo)準(zhǔn)品 | Linagliptin |
利格列汀雜質(zhì)1 | 2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide |
利格列汀雜質(zhì)2 | (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)3 | N-Phthalimide-linagliptin |
利格列汀雜質(zhì)4 | N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide |
利格列汀雜質(zhì)5 | (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid |
利格列汀雜質(zhì)6 | 8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1) |
利格列汀雜質(zhì)7 | Linagliptin Diene Impurity |
利格列汀雜質(zhì)8 | Linagliptin Acetamide |
利格列汀雜質(zhì)9 | (R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)10 | (R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)11 | 8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)12 | (R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)13 | (R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)14 | (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)15 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide |
利格列汀雜質(zhì)16 | (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)17 | (S)-Linagliptin |
利格列汀雜質(zhì)18 | N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
利格列汀雜質(zhì)19 | (R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)20 | (R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
利格列汀雜質(zhì)21 | (R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)22 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)23 | (S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)24 | (R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)25 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide |
深圳遠(yuǎn)揚(yáng)化學(xué)除國產(chǎn)雜質(zhì)對照品外,代理有加拿大TLC雜質(zhì)對照品,TRC雜質(zhì)對照品,MC雜質(zhì)對照品,英國NIBSC標(biāo)準(zhǔn)品,美國CIL同位素標(biāo)準(zhǔn)品,NIST標(biāo)準(zhǔn)物質(zhì),歐洲標(biāo)準(zhǔn)局IRMM標(biāo)準(zhǔn)物質(zhì)等,原廠訂貨,質(zhì)量保證。
? 美國NIST標(biāo)準(zhǔn)物質(zhì)部分產(chǎn)品列表:
2573 | Lead Paint Film (Red), Nominal 1.0 mg/cm2 | 1 +blank |
90 | Ferrophosphorus | 75 g |
2585 | Organic Contaminants in House Dust | 10 g |
915b | Calcium Carbonate | 20 g |
659 | Particle Size Distribution Standard for Sedigraph Calibration | set (5) |
3109a | Calcium (Ca) Standard Solution | 5 x 10 mL |
3671 | Nicotine Metabolites in Human Urine (Frozen) | 3 x 10 mL |
1048 | Cup Furnace Smoke Toxicity Method Standard | 8 sheets |
72g | Low Alloy Steel (AISI 4130) | 150 g |
C2418 | High-Purity Lead | disk |
3669 | Arsenic Species in Frozen Human Urine (Elevated Levels) | 5 x 1.5mL |
1754 | Low-Alloy Steel, AISI 4320 | rod |
1544 | Fatty Acids and Cholesterol in a Frozen Diet Composite | 4x15 g |
2113 | Dynamic Impact Force Verification Specimens (Nominal 33kN) | set |
882 | Nickel-Copper Alloy (65Ni-31Cu-3Al) | 100 g |
1075a | Aluminum 2-Ethylhexanoate | 5 g |
1958 | Organic Contaminants in Fortified Human Serum (Freeze-Dried) | 5 x 10 mL |
423 | Molybdenum Oxide Concentrate | 1 pouch x 60 g |
3117a | Europium (Eu) Standard Solution | 5x10 mL |
1484a | Linear Polyethylene | 0.3 g |
2841 | Semiconductor Thin Film: AlxGa1-xAs Epitaxial Layers (Al mole fraction x near 0.20) | disk |
2580 | Powdered Paint Nominal 4% Lead | 30 g |
858 | Aluminum Alloy 6011 | 35 g |
154c | Titanium Dioxide | 90 g |
17f | Sucrose Optical Rotation | 60 g |
請輸入賬號
請輸入密碼
請輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購買風(fēng)險,建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。